Clinical Trial Update: A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone [Phase 3]

View source ↗

Summary

A Phase 3 study of RAY1225 in participants with type 2 diabetes not controlled by diet and exercise; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RAY1225

Snippet

Sponsor: Guangdong Raynovent Biotech Co., Ltd | Conditions: T2DM | Phase 3 | Status: NOT_YET_RECRUITING